Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Arcutis Biotherapeutics (ARQT) Other Non Operating Income: 2020-2024

Historic Other Non Operating Income for Arcutis Biotherapeutics (ARQT) over the last 5 years, with Dec 2024 value amounting to $16.2 million.

  • Arcutis Biotherapeutics' Other Non Operating Income fell 51.34% to $2.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.6 million, marking a year-over-year decrease of 40.60%. This contributed to the annual value of $16.2 million for FY2024, which is 37.22% up from last year.
  • Arcutis Biotherapeutics' Other Non Operating Income amounted to $16.2 million in FY2024, which was up 37.22% from $11.8 million recorded in FY2023.
  • In the past 5 years, Arcutis Biotherapeutics' Other Non Operating Income ranged from a high of $16.2 million in FY2024 and a low of $173,000 during FY2021.
  • For the 3-year period, Arcutis Biotherapeutics' Other Non Operating Income averaged around $11.3 million, with its median value being $11.8 million (2023).
  • As far as peak fluctuations go, Arcutis Biotherapeutics' Other Non Operating Income plummeted by 82.11% in 2021, and later surged by 3,264.74% in 2022.
  • Yearly analysis of 5 years shows Arcutis Biotherapeutics' Other Non Operating Income stood at $967,000 in 2020, then crashed by 82.11% to $173,000 in 2021, then soared by 3,264.74% to $5.8 million in 2022, then spiked by 102.47% to $11.8 million in 2023, then spiked by 37.22% to $16.2 million in 2024.